Medical devices, the application of Regulation (EU) 2017/745 is underway

From 26 May 2021 the Regulation (EU) 2017/745. Il regolamento modifica le norme che disciplinano il sistema dei dispositivi medici, tenendo conto degli sviluppi degli ultimi vent’anni, con l’obiettivo di garantire un quadro normativo solido, idoneo a mantenere un elevato livello di safety.

National authorities, notified bodies, manufacturers, economic operators, health institutions and the other subjects involved will have to collaborate to improve the medical device system in the renewed regulatory framework provided for by the regulation.

The new regulatory context

Regulation (EU) 2017/745, based on the principles of New Legislative Framework, in continuità con i principi del New Approach si pone l’obiettivo di elevare gli standard di qualità e sicurezza dei prodotti e creare contemporaneamente un quadro legislativo sostenibile, favorevole all’innovation which places the EU as guarantor of global health and the proper functioning of the internal market in the medical devices sector.

The May 26, 2021 is, formally, the date from which the full applicability of Regulation 2017/745 takes effect, however, as envisaged by the same, the non-operation of Eudamed allows the use of transitional solutions by the Member States as regards the registration of devices and operators economic, certification notifications, surveillance and clinical investigations.

Furthermore, a derogation period begins in which some of the devices compliant with the directives will be able to continue to be legitimately placed on the market (legacy devices), at the latest until 26 May 2024.

The Ministry of Health engaged on several fronts

The Ministry of Health, Competent Authority and Responsible Authority for Notified Bodies, is working on several fronts, including:

For more information, consult the page:

Ministero della Salute – 25 maggio 2021

Exit mobile version